Trends in HIV Testing Among US Adults, Aged 18–64 Years, 2011–2017

Patel, Deesha A.; Johnson, Christopher H.; Krueger, Amy; Maciak, Barbara J.; Belcher, Lisa; Harris, Norma; DiNenno, Elizabeth

doi:10.1007/s10461-019-02689-0

Cited by 37 publications

(33 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, other data are needed to assess the extent to which testing in the previous 12 months includes persons at high risk of HIV infection who should be tested/retested at least annually per the 2006 testing recommendations. 7,33 Progress has been made for both ever-tested and tested for HIV in the previous 12 months nationally, 20 but in our analysis, progress varied by state. Accelerated testing is needed to diagnose HIV infections among persons unaware of their infection.…”

Section: Discussionmentioning

confidence: 84%

“…19 In 2017, nearly half (45.9%) of US adults aged 18-64 years reported having ever been tested for HIV and 1 of 7 (14.8%) reported having been tested in the previous year. 20 Although published studies describe national trends in HIV testing overall and for population subgroups (by age, sex, race/ethnicity, and HIV risk behavior), 20,21 less information is available on state trends in HIV testing. State HIV testing estimates have been reported by individual states.…”

mentioning

confidence: 99%

See 1 more Smart Citation

State Trends in HIV Testing Among US Adults Aged 18-64 Years, 2011-2017

et al. 2020

Self Cite

View full text Add to dashboard Cite

Objectives HIV testing identifies persons living with HIV and can lead to treatment, decreased risk behaviors, and reduced transmission. The objective of our study was to describe state-level trends in HIV testing in the general US adult population aged 18-64 years, for both ever tested for HIV and tested for HIV in the previous 12 months. Methods Using 2011-2017 Behavioral Risk Factor Surveillance System data, we estimated the percentage of the state population, plus the District of Columbia, aged 18-64 years ever tested for HIV and tested for HIV in the previous 12 months. The 50 states and the District of Columbia were grouped according to the estimated prevalence of HIV in 2011. We used orthogonal contrasts to calculate P values for linear trends. Results The percentage of the population ever tested for HIV increased significantly in 23 states during 2011-2017, whereas the percentage tested for HIV in the previous 12 months increased significantly in 8 states. In 2017, the mean percentage ever tested for HIV in states with a high prevalence of HIV was 8.6 percentage points higher than the mean percentage in states with a low prevalence of HIV (48.5% vs 39.9%); the mean increase in the percentage ever tested was highest (11.4%) in states with a low prevalence of HIV. Conclusion Enhanced efforts by states to make HIV testing simple, accessible, and routine are needed to reduce the number of persons who are not aware of their infection.

show abstract

Section: Discussionmentioning

confidence: 84%

mentioning

confidence: 99%

State Trends in HIV Testing Among US Adults Aged 18-64 Years, 2011-2017

et al. 2020

Self Cite

View full text Add to dashboard Cite

show abstract

“…17 The same statistic increased from 17% to 18% during 2011–2017 based on Behavioral Risk Factor Surveillance System (BRFSS) data. 32 However, this change was not significant, suggesting little progress in improving early HIV diagnosis among Hispanics. Culturally-sensitive evidence-based HIV testing initiatives are, therefore, recommended to reach the Hispanic population.…”

Section: Discussionmentioning

confidence: 96%

Identifying subgroups within at-risk populations that drive late HIV diagnosis in a Southern U.S. state

et al. 2020

View full text Add to dashboard Cite

We aimed to identify subgroups within age, racial/ethnic, and transmission categories that drive increased risk for late HIV diagnosis (LHD). A 1996–2013 retrospective study of HIV-diagnosed individuals (N = 77,844) was conducted. The proportion of individuals with LHD (AIDS diagnosis within 365 days of HIV diagnosis) was determined, stratified by age, race/ethnicity, and transmission category. Logistic regression with interaction terms was used to identify groups/subgroups at risk for LHD during 1996–2001, 2002–2007, and 2008–2013. Respectively, 78%, 27%, 38%, and 31% were male, White, Black, and Hispanic. Overall, 39% had LHD with a 6.7% reduction for each year increase (OR = 0.93, 95% CI = 0.93–0.94, p < 0.01). Older age was significantly associated with increased odds of LHD (OR range = 1.90–4.55). Compared to their White counterparts, all Hispanic transmission categories (OR range = 1.31–2.58) and only Black female heterosexuals and men who have sex with men (MSM) (OR range = 1.14–1.33) had significantly higher odds of LHD during 1996–2001 and/or 2002–2007. Significance was limited to Hispanic MSM (all age categories), MSM/IDUs (30–59 years), and heterosexuals (18–29 years) and Black MSM (30–39 years) during 2008–2013. Older individuals and Hispanics (driven by MSM) are at increased risk for LHD. HIV testing interventions directed at seniors and Hispanic MSM can further reduce rates of LHD.

show abstract

“…For those that test HIVnegative, the prevention continuum includes behavioral and biomedical prevention services, including risk reduction counseling and linkage to pre-exposure prophylaxis (PrEP). In a recent study examining trends in HIV testing among US adults, 46% of adults had tested for HIV in their lifetime, with highest rates of being ever tested among Black adults (~69%) and Latinx (~48%) persons [5]. Among those that report an HIV risk factor (5.1% of persons; risk factors including injection drug use, a sexually transmitted infection in the past year, giving or receiving money or drugs in exchange for sex in the past year, or condomless anal sex), approximately 65% had ever tested for HIV.…”

Section: Introductionmentioning

confidence: 99%

A Systematic Review of Technology-Assisted HIV Testing Interventions

et al. 2020

View full text Add to dashboard Cite

Purpose of ReviewThe purpose of this review is to describe and assess the literature on mobile health (mHealth) and other technology-based HIV testing interventions published in the 5-year period from 2015 to 2020. Recent Findings We identified 18 published technology-based studies, 6 of which were efficacy trials and the remaining 12 were either pilot randomized controlled trials (RCTs) or quasi-experimental studies. Most (n = 10) interventions were conducted outside the USA, including countries in Sub-Saharan Africa (n = 4), China (n = 3), Latin America (n = 2), and India (n = 1). All efficacy trials showed some evidence of efficacy, although uptake of HIV testing was low among in intervention trials that consisted of a low number of text messages. Most pilot RCTs demonstrated high levels of feasibility and acceptability, as well as some evidence that the intervention participants benefited more than the control group. Many non-randomized trials similarly reported positive appraisal by study participants. Recommendations for future research and practice by the authors of the studies reviewed here are summarized. Summary Technology-assisted HIV testing interventions may be an important strategy to reach national and global targets for HIV status awareness in the general population and for most at-risk groups. Although there appears to be growing evidence of their benefit, questions linger regarding how to leverage existing social media platforms to promote HIV testing, which interventions work for what populations, and best practices for scaling up mHealth and other technology-based interventions.

show abstract

Trends in HIV Testing Among US Adults, Aged 18–64 Years, 2011–2017

Cited by 37 publications

References 16 publications

State Trends in HIV Testing Among US Adults Aged 18-64 Years, 2011-2017

State Trends in HIV Testing Among US Adults Aged 18-64 Years, 2011-2017

Identifying subgroups within at-risk populations that drive late HIV diagnosis in a Southern U.S. state

A Systematic Review of Technology-Assisted HIV Testing Interventions

Contact Info

Product

Resources

About